Viatris Inc
NASDAQ:VTRS

Watchlist Manager
Viatris Inc Logo
Viatris Inc
NASDAQ:VTRS
Watchlist
Price: 9.07 USD -0.22%
Market Cap: 10.8B USD

Relative Value

The Relative Value of one VTRS stock under the Base Case scenario is hidden USD. Compared to the current market price of 9.07 USD, Viatris Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VTRS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
49
vs Industry
76
Median 3Y
0.8
Median 5Y
0.8
Industry
2.5
Forward
0.8
vs History
vs Industry
1
Median 3Y
5.6
Median 5Y
5.4
Industry
21.5
Forward
4.1
vs History
41
vs Industry
48
Median 3Y
4.6
Median 5Y
4.6
Industry
16.6
vs History
vs Industry
29
Median 3Y
9.6
Median 5Y
12.1
Industry
24.9
vs History
28
vs Industry
72
Median 3Y
0.6
Median 5Y
0.6
Industry
2.1
vs History
74
vs Industry
56
Median 3Y
1.8
Median 5Y
1.8
Industry
2.7
Forward
1.7
vs History
57
vs Industry
50
Median 3Y
4.1
Median 5Y
4.2
Industry
5.2
vs History
42
vs Industry
45
Median 3Y
5.4
Median 5Y
5.4
Industry
12.8
Forward
5.9
vs History
41
vs Industry
26
Median 3Y
13
Median 5Y
15.3
Industry
16.3
Forward
6.4
vs History
46
vs Industry
37
Median 3Y
10.5
Median 5Y
10.7
Industry
14.9
vs History
47
vs Industry
29
Median 3Y
12.7
Median 5Y
12.8
Industry
17.9
vs History
9
vs Industry
70
Median 3Y
0.6
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

VTRS Competitors Multiples
Viatris Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Viatris Inc
NASDAQ:VTRS
10.8B USD 0.7 -2.8 5.5 15.8
US
Eli Lilly and Co
NYSE:LLY
776.8B USD 15.9 70 37.5 41
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
377.9B USD 4.2 17.3 12.7 16.6
DK
Novo Nordisk A/S
CSE:NOVO B
2.3T DKK 7.6 22 15.2 17.4
CH
Roche Holding AG
SIX:ROG
214.4B CHF 3.5 25.9 9.7 11.4
CH
Novartis AG
SIX:NOVN
190.6B CHF 4.4 18.3 10.8 14.4
UK
AstraZeneca PLC
LSE:AZN
170B GBP 4.2 29.7 131.4 198.1
US
Merck & Co Inc
NYSE:MRK
205.5B USD 3.2 11.8 8.8 10.6
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
141.1B USD 2.3 17.9 7.6 10.7
P/E Multiple
Earnings Growth PEG
US
Viatris Inc
NASDAQ:VTRS
Average P/E: 26.6
Negative Multiple: -2.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
70
50%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.3
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
22
18%
1.2
CH
Roche Holding AG
SIX:ROG
25.9
32%
0.8
CH
Novartis AG
SIX:NOVN
18.3
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
29.7
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.8
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.9
31%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Viatris Inc
NASDAQ:VTRS
Average EV/EBITDA: 395.2
5.5
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
37.5
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.7
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
15.2
13%
1.2
CH
Roche Holding AG
SIX:ROG
9.7
5%
1.9
CH
Novartis AG
SIX:NOVN
10.8
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
131.4
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.8
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Viatris Inc
NASDAQ:VTRS
Average EV/EBIT: 1 699.4
15.8
33%
0.5
US
Eli Lilly and Co
NYSE:LLY
41
32%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.6
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
17.4
14%
1.2
CH
Roche Holding AG
SIX:ROG
11.4
6%
1.9
CH
Novartis AG
SIX:NOVN
14.4
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
198.1
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.6
11%
1
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1